Puma Biotechnology reported $95.65M in Cash and Equivalent for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 455.51M 215.44M
Agios Pharmaceuticals AGIO:US $ 1888.02M 1760.59M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 379.54M 117.04M
Amgen AMGN:US $ 6112M 154M
Arena Pharmaceuticals ARNA:US $ 432.98M 213.43M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 667.31M 18.16M
Bluebird Bio BLUE:US $ 439.71M 122.01M
Clovis Oncology CLVS:US $ 190.92M 49.31M
Daiichi Sankyo 4568:JP Y 380547M 139527M
Esperion Therapeutics ESPR:US $ 217.94M 87.02M
Gilead Sciences GILD:US $ 6245M 248M
Glaxosmithkline GSK:US $ 4757M 1535M
Intercept Pharmaceuticals ICPT:US $ 92.95M 34.8M
Macrogenics MGNX:US $ 218.5M 37.36M
Mirati Therapeutics MRTX:US $ 294.89M 570.28M
Moderna Inc MRNA:US 5.44B 2.82B
Novartis NOVN:VX SF 3801M 5857M
Pfizer PFE:US $ 1768M 16M
Ptc Therapeutics PTCT:US $ 146.63M 62.18M
Puma Biotechnology PBYI:US $ 95.65M 10.36M
Regeneron Pharmaceuticals REGN:US $ 1437.9M 755.8M
Sangamo Biosciences SGMO:US $ 122.98M 8.35M
Sarepta Therapeutics SRPT:US $ 1481.84M 20.81M
Seattle Genetics SGEN:US $ 373.71M 184.71M
Spectrum Pharmaceuticals SPPI:US $ 69.52M 23.51M
Takeda 4502:JP Y 966222M 348587M
Tg Therapeutics TGTX:US $ 471.51M 317.95M
Ultragenyx Pharmaceutical RARE:US $ 383.79M 329.73M
Vanda Pharmaceuticals VNDA:US $ 72.13M 11.1M
Vertex Pharmaceuticals VRTX:US $ 6923.97M 935.78M
YTE INCY:US $ 1962.39M 449.38M